[Pulmonary infiltration of acute monoblastic leukemia diagnosed by transbronchial lung biopsy]

Naonori Harada1, Takahiko Nakane1, Hiroshi Okamura1

  • 1Hematology, Graduate School of Medicine, Osaka City University.

Insights

A 65-year-old woman with acute monoblastic leukemia experienced lung infiltration. Prompt diagnosis via lung biopsy and intensive chemotherapy led to remission, highlighting the importance of pathological confirmation for effective treatment.

Area of Science:

  • Hematology
  • Pulmonology
  • Oncology

Background:

  • Acute myeloid leukemia (AML) can present with pulmonary complications, often mimicking infections or heart failure.
  • Distinguishing leukemic lung infiltration from other pulmonary issues in AML patients is clinically challenging.

Observation:

  • A 65-year-old female presented with antibiotic-resistant fever, hypoxemia, and hyperleukocytosis, diagnosed with acute monoblastic leukemia.
  • Chest CT revealed interlobular septal thickening, ground-glass opacity, and a nodular shadow, initially unresponsive to infectious disease and heart failure treatments.
  • Transbronchial lung biopsy confirmed pulmonary leukemic infiltration, prompting intensive chemotherapy.

Findings:

  • Intensive chemotherapy resulted in the resolution of abnormal lung shadows on CT scans.
  • Complete hematological remission was achieved in the patient.
  • Pathological confirmation of pulmonary leukemic infiltration was crucial for successful treatment.

Implications:

  • Accurate pathological diagnosis of pulmonary leukemic infiltration is vital for guiding appropriate therapy in AML patients.
  • This case underscores the importance of considering leukemic infiltration in AML patients with unexplained pulmonary symptoms.
  • Timely and accurate diagnosis leading to targeted chemotherapy can significantly improve patient outcomes in cases of AML-related lung disease.